Neural basis of inhalant abuse

Drug and Alcohol Dependence

Volumn 51, Issue 1-2, 1998, Pages 207-214

  Balster, Robert L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN RECEPTOR; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; NITROUS OXIDE; OPIATE RECEPTOR; VOLATILE AGENT;

ANALGESIA; DOPAMINERGIC SYSTEM; HUMAN; INHALATION; NEUROBIOLOGY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REINFORCEMENT; REVIEW; SUBSTANCE ABUSE;

EID: 0032104703     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00078-7     Document Type: Article

References (86)

1. Adler, M.W., 1975. Pharmacology of flurothyl: Laboratory and clinical applications. In: Essman, W., Valzelli, L. (Eds.), Current Developments in Psychopharmacology, Vol. 2. Spectrum Publications, New York, pp. 31-78.
2. 45Ca uptake by rat brain microvesicles. Neurochem. Res. 19, 1515-1520.
3. Balster, R.L., 1987. Abuse potential evaluation of inhalants. Drug Alcohol Depend. 49, 7-15.
4. th Annual Scientific Meeting, NIDA Research Monograph 174, NIH Publication No. 97-4236. National Institute on Drug Abuse, Rockville, MD, pp. 3-8.
5. Balster, R.L., Bowen, S.E., Evans, E.B., Tokarz, M.E., 1997. Evaluation of the acute behavioral effects and abuse potential of a C8-C9 isoparaffin solvent. Drug Alcohol Depend. 46, 125-135.
6. Berkowitz, B.A., Ngai, S.H., Finck, A.D., 1976. Nitrous oxide 'analgesia': resemblance to opiate action. Science 194, 967-968.
7. Bowen, S.E., Balster, R.L., 1996. Effects of inhaled 1,1,1-trichloroethane on locomotor activity in mice. Neurotoxicol. Teratol. 18, 77-81.
8. Bowen, S.E., Balster, R.L., 1997a. Desflurane, isoflurane and ether produce ethanol-like discriminative stimulus effects in mice. Pharmacol. Biochem. Behav. 57, 191-198.
9. Bowen, S.E., Balster, R.L., 1997b. A comparison of the acute behavioral effects of inhaled amyl, ethyl, and butyl acetate in mice. Fundam. Appl. Toxicol. 35, 138-196.
10. Bowen, S.E., Wiley, J.L., Balster, R.L., 1996a. The effects of abused inhalants on mouse behavior in an elevated plus-maze. Eur. J. Pharmacol. 312, 131-136.
11. Bowen, S.E., Wiley, J.L., Evans, E.B., Tokarz, M.E., Balster, R.L., 1996b. Functional observational battery comparing the effects of ethanol, 1,1,1-trichloroethane, ether and flurothyl. Neurotoxicol. Teratol. 18, 557-585.
12. Caton, P.W., Tousman, S.A., Quock, R.M., 1994. Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze. Pharmacol. Biochem. Behav. 48, 689-692.
13. Cruz, S.L., Balster, R.L., Woodward, J.J., 1997. Effects of toluene and other abused solvents on recombinant NMDA receptors expressed in Xenopus oocytes. Soc. Neurosci. Abs. 23, 948.
14. Cruz, S.L., Mirshahi, T., Thomas, B., Balster, R.L., Woodward, J.J., 1998. Effects of the abused solvent toluene on recombinant NMDA and nonNMDA receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther., in press.
15. Czech, D.A., Green, D.A., 1992. Anxiolytic effects of nitrous oxide in mice in the light-dark and holeboard exploratory tests. Psychopharmacology 109, 315-320.
16. Czech, D.A., Quock, R.M., 1993. Nitrous oxide induces anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker. Psychopharmacology 113, 211-216.
17. Daniell, L.C., 1990. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics. Pharmacol. Biochem. Behav. 36, 111-115.
18. Davies, P.A., Hanna, M.C., Hales, T.G., Kirkness, E.F., 1997. Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. Nature 385, 820-823.
19. Dohrn, C., Lichtor, J.L., Finn, R.S., Uitvlugt, A., Coalson, D.W., Rupani, G., de Wit, H., Zacny, J.P., 1992. Subjective and psychomotor effects of nitrous oxide in healthy volunteers. Behav. Pharmacol. 3, 19-30.
20. Dong, A., Huang, P., Zhao, X.-J., Sampath, V., Caughey, W.S., 1994. Characterization of sites occupied by anesthetic nitrous oxide within proteins by infrared spectroscopy. J. Biol. Chem. 269, 23911-23917.
21. Emmanouil, D., Johnson, C.H., Quock, R.M., 1994. Nitrous oxide anxiolytic effect in mice in the elevated plus maze: Mediation by benzodiazepine receptors. Psychopharmacology 115, 167-172.
22. Evans, E.B., Balster, R.L., 1991. CNS depressant effects of volatile organic solvents. Neurosci. Biobehav. Rev. 15, 233-241.
23. Evans, E.B., Balster, R.L., 1992. Effects of methoxyflurane and flurothyl in mice trained to discriminate pentylenetetrazole from saline. Behav. Pharmacol 3, 465-473.
24. Evans, E.B., Balster, R.L., 1993. Inhaled 1,1,1-trichloroethane produced physical dependence in mice: Effects of drugs and vapors on withdrawal. J. Pharmacol. Exp. Ther. 264, 726-733.
25. Finck, A.D., Samaniego, E., Ngai, S.H., 1995. Nitrous oxide selectively releases Met5-enkephalin and Met5-enkephalin-Arg6-Phe7 into canine third ventricular cerebrospinal fluid. Anesth. Analg. 80, 664-670.
26. Franks, N.P., Lieb, W.R., 1984. Do general anaesthetics act by competitive binding to specific receptors? Nature 510, 599-601.
27. Franks, N.P., Lieb, W.R., 1990. Mechanisms of general anesthesia. Environ. Health Perspect. 87, 199-205.
28. Galinkin, J.L., Janiszewski, D.J., Young, C.J., Klafta, J.M., Klock, P.A., Coalson, D.W., Apfelbaum, J.L., Zacny, J.P., 1997. Subjective, psychomotor, cognitive, and analgesic effects of subanesthetic concentrations of sevoflurane and nitrous oxide. Anesthesiology 87, 1082-1088.
29. Gillman, M.A., Lichtigfeld, F.J., 1994. Pharmacology of psychotropic analgesic nitrous oxide as a multipotent opioid agonist. Int. J. Neurosci. 76, 5-12.
30. Goode, E., Troiden, R.R., 1979. Amyl nitrite use among homosexual men. Am. J. Psychiatry 136, 1067-1069.
31. Grant, K.A., 1994. Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav. Pharmacol. 5, 383-404.
32. Harris, R.A., Mihic, S.J., Dildy-Mayfield, J.E., Machu, T.K., 1995. Actions of anesthetics on ligand-gated ion channels: Role of receptor subunit composition. FASEB J. 9, 1454-1462.
33. Haverkos, H.W., Kopstein, A.N., Wilson, H., Drotman, P., 1994. Nitrite inhalants: History, epidemiology, and possible links to AIDS. Environ. Health Perspect. 102, 858-861.
34. Hodges, B.L., Gagnon, M.J., Gillespie, T.R., Breneisen, J.R., O'Leary, D.F., Kara, S., Quock, R.M., 1994. Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade. J. Pharmacol. Exp. Ther. 269, 596-600.
35. Hynes, M.D., Hymson, D.L., 1984. Nitrous oxide generalizes to a discriminative stimulus produced by ethylketocyclazocine but not morphine. Eur. J. Pharmacol. 105, 155-159.
36. Jones, M., Brooks, P.A., Harrison, N.L., 1992. Enhancement of γ-aminobutyric acid-activated Cl currents in cultured rat hippocampal neurones by three volatile anaesthetics. J. Physiol. 449, 279-293.
37. Kondo, H., Huang, J., Ichihara, G., Kamijima, M., Saito, I., Shibata, E., Ono, Y., Hisanaga, N., Takeuchi, Y., Nakahara, D., 1995. Toluene induces behavioral activation without affecting striatal dopamine metabolism in the rat: Behavioral and microdialysis studies. Pharmacol. Biochem. Behav. 41, 97-101.
38. Levine, J.D., Gordon, N.C., Fields, H.L., 1982. Naloxone fails to antagonize nitrous oxide analgesia for clinical pain. Pain 13, 165-170.
39. Maickel, R.P., 1988. The fate and toxicity of butyl nitrites. In: Haverkos, H.W., Dougherty, J.A. (Eds.), Health Hazards of Nitrite Inhalants. NIDA Research Monograph 83. DHHS Pub. No. (ADM) 88-1573. National Institute on Drug Abuse, Rockville, MD, pp. 15-27.
40. McDonald, C.E., Gagnon, M.J., Ellenberger, E.A., Hodges, B.L., Ream, J.K., Tousman, S.A., Quock, R.M., 1994. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats. J. Pharmacol. Exp. Ther. 269, 601-608.
41. McFadden, D.P., Carlson, G.P., Maickel, R.P., 1981. The role of methemoglobin in acute butyl nitrite toxicity in mice. Fundam. Appl. Toxicol. 1, 448-451.
42. Meyer, H.D., 1899. Zur Theorie de Alkoholnarkose. I. Mitt Welche Eigenschsaft der Anästhetika bedingt ihre narkotishche Wirkung? Arch. Exp. Pathol. Pharmakol. 42, 109-118.
43. Mihic, S.J., McQuilkin, S.J., Eger, E.I., Ionescu, P., Harris, R.A., 1994. Potentiation of γ-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia. J. Pharmacol. Exp. Ther. 46, 851-857.
44. A and glycine receptors. Nature 389, 385-389.
45. Miller, K.W., 1985. The nature of the site of general anesthesia. Int. Rev. Neurobiol. 27, 1-61.
46. A receptor complex. Brain Res. 615, 101-106.
47. Morton, H.G., 1987. Occurrence and treatment of solvent abuse in children and adolescents. Pharmacol. Ther. 33, 449-469.
48. Moser, V.C., Balster, R.L., 1985. Acute motor and lethal effects of inhaled toluene, 1,1,1-trichloroethane, halothane, and ethanol in mice: Effects of exposure duration. Toxicol. Appl. Pharmacol. 77, 285-291.
49. Murad, F., 1986. Cytosolic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78, 1-5.
50. Murray, M.J., Murray, W.J., 1980. Nitrous oxide availability. J. Clin. Pharmacol. 20, 202-205.
51. Narimatsu, E., Tsai, Y.-C., Gerhold, T.D., Kamath, S.H., Davies, L.R., Sokoll, M.D., 1996. A comparison of the effect of halothane on N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated excitatory synaptic transmission in the hippocampus. Anesth. Analg. 82, 843-847.
52. Ohara, A., Mashimo, T., Zhang, P., Inagaki, Y., Shibuta, S., Yoshiya, I., 1997. A comparative study of the antinociceptive action of xenon and nitrous oxide in rats. Anesth. Analg. 85, 931-936.
53. Overton, C.E., 1901. Studien über die Narkose: Zugleich ein Beitrag zu allgemeinen Pharmakologie. G. Fischer, Jena.
54. Quock, R.M., Best, J.A., Chen, D.C., Vaughn, L.K., Portoghese, P.S., Takemori, A.E., 1990. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal κ-opioid receptors. Eur. J. Pharmacol. 175, 97-100.
55. Quock, R.M., Curtis, B.A., Reynolds, B.J., Mueller, J.L., 1993. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice. J. Pharmacol. Exp. Ther. 267, 117-122.
56. Quock, R.M., Kouchich, F.J., Tseng, L.-F., 1986. Influence of nitrous oxide upon regional brain levels of methionine-enkephalin-like immunoreactivity in rats. Brain Res. Bull. 16, 321-323.
57. Rea, T.M., Nash, J.F., Zabik, J.E., Born, G.S., Kessler, W.V., 1984. Effects of toluene inhalation on brain biogenic amines in the rat. Toxicology 31, 143-150.
58. Rees, D.C., Knisely, J.S., Balster, R.L., Jordan, S., Breen, T.J., 1987a. Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice. J. Pharmacol. Exp. Ther. 241, 507-515.
59. Rees, D.C., Knisely, J.S., Breen, T.J., Balster, R.L., 1987b. Toluene, halothane, 1,1,1-trichloroethane and oxazepam produce ethanol-like discriminative stimulus effects in mice. J. Pharmacol. Exp. Ther. 243, 931-937.
60. Rees, D.C., Knisely, J.S., Jordan, S., Balster, R.L., 1987c. Discriminative stimulus properties of toluene in the mouse. Toxicol. Appl. Pharmacol. 88, 97-104.
61. Riegel, A.C., French, E.D., 1998. Toluene alters rat VTA dopamine (DA) and non-DA neurons through a dose-dependent mechanism. In: Harris, L.S. (Ed.). Problems of Drug Dependence 1997, NIDA Research Monograph Series, in press.
62. Rosenberg, H., Orkin, F.K., Springstead, J., 1979. Abuse of nitrous oxide. Anesth. Analg. 58, 104-106.
63. Russell, R.W., Steinberg, H., 1955. Effects of nitrous oxide on reactions to 'stress'. Q. J. Exp. Psychol. 7, 67-73.
64. Sharp, C.W., 1992. Introduction to inhalant abuse. In: Sharp, C.W., Beauvais, F., Spence, R. (Eds.). Inhalant Abuse: A Volatile Research Agenda. NIDA Research Monograph 192. NIH Publication No. 93-3480, Institute on Drug Abuse, Rockville, MD, pp. 1-10.
65. Sigell, L.T., Kapp, F.T., Fusaro, G.T., Nelson, E.D., Falck, R.S., 1978. Popping and snorting volatile nitrites: A current fad for getting high. Am. J. Psychiatry 135, 1216-1218.
66. Smith, R.A., Wilson, M., Miller, K.W., 1978. Naloxone has no effect on nitrous oxide anesthesia. Anesthesiology 49, 6-8.
67. Snyder, S.H., 1992. Nitric oxide: First in a new class of neurotransmitters. Science 257, 494-496.
68. Stengård, K., Höglund, G., Ungerstedt, U., 1994. Extracellular dopamine levels within the striatum increase during inhalation exposure to toluene: A microdialysis study in awake, freely moving rats. Toxicol. Lett. 71, 245-255.
69. Tegeris, J.S., Balster, R.L., 1994. A comparison of the acute behavioral effects of alkylbenzenes using a functional observational battery in mice. Fundam. Appl. Toxicol. 22, 240-250.
70. von Euler, G., 1994. Toluene and dopaminergic transmission. In: Isaacson, R.L., Jensen, K.F. (Eds.), The Vulnerable Brain and Environmental Risk, Volume 3: Toxins in Air and Water. Plenum Press, New York, pp. 301-321.
71. Wood, R.W., 1982. Stimulus properties of inhaled substances. An update. In: Mitchell, C.L. (Ed.), Nervous System Toxicology. Raven Press, New York, pp. 199-212.
72. Wood, R.W., Coleman, J.B., Schuler, R., Cox, C., 1984. Anticonvulsant and antipunishment effects of toluene. J. Pharmacol. Exp. Ther. 230, 407-412.
73. Wood, R.W., Grubman, J., Weiss, B., 1977. Nitrous oxide self-administration in the squirrel monkey. J. Pharmacol. Exp. Ther. 202, 491-499.
74. Wood, R.W., Colotla, V.C., 1990. Biphasic changes in mouse motor activity during exposure to toluene. Fundam. Appl. Toxicol. 14, 6-14.
75. Woolverton, W.L., Balster, R.L., 1981. Behavioral and lethal effects of combinations of oral ethanol and inhaled 1,1,1-trichloroethane in mice. Toxicol. Appl. Pharmacol. 59, 1-7.
76. Yagi, M., Mashimo, T., Kawaguchi, T., Yoshiya, I., 1995. Analgesic and hypnotic effects of subanesthetic concentrations of xenon in human volunteers: Comparison with nitrous oxide. Br. J. Anaesth. 74, 670-673.
77. Yamawaki, W., Sarai, K., 1982. Effects of toluene inhalation on locomotor activity and brain catecholamine levels in rats. Yakubutsu Seishin Kodo 1, 57-59.
78. Yanagita, T., Takahashi, S., Ishida, K., Funamoto, H., 1970. Voluntary inhalation of volatile anesthetics and organic solvents by monkeys. Jpn. J. Clin. Pharmacol. 1, 13-16.
79. Yavich, L., Patkina, N., Zvartau, E., 1994. Experimental estimation of addictive potential of a mixture of organic solvents. Eur. Neuropsychopharmacol. 4, 111-118.
80. Yavich, L., Zvartau, E., 1994. A comparison of the effects of individual organic solvents and their mixture on brain stimulation reward. Pharmacol. Biochem. Behav. 48, 661-664.
81. Zacny, J.P., Coalson, D.W., Lichtor, J.L., Yajnik, S., Thapar, P., 1994a. Effects of naloxone on the subjective and psychomotor effects of nitrous oxide in humans. Pharmacol. Biochem. Behav. 49, 573-578.
82. Zacny, J.P., Klafta, J.M., Coalson, D.W., Marks, S., Young, C.J., Klock, A., Toledano, A.Y., Jordan, N., Apfelbaum, J.L., 1996. The reinforcing effects of brief exposures to nitrous oxide in healthy volunteers. Drug Alcohol Depend. 42, 197-200.
83. Zacny, J.P., Sadeghi, P., Klafta, J.L., Klock, P.A., Coalson, D.W., 1998. Testing the abuse potential of sevoflurane in healthy volunteers: Implications for anesthesiologists. Anesth. Analg., in press.
84. Zacny, J.P., Sparacino, G., Hoffmann, P.M., Martin, R., Lichtor, J.L., 1994b. The subjective, behavioral and cognitive effects of subanesthetic concentrations of isoflurane and nitrous oxide in healthy volunteers. Psychopharmacology 114, 409-416.
85. Zacny, J.P., Yajnik, S., Coalson, D., Lichtor, J.L., Apfelbaum, J.L., Rupan, G., Young, C., Thapar, P., Klafta, J., 1995. Flumazenil may attenuate some subjective effects of nitrous oxide in humans: A preliminary report. Pharmacol. Biochem. Behav. 51, 815-819.
86. Zuniga, J.R., Joseph, S.A., Knigge, K.M., 1987. The effects of nitrous oxide on the central endogenous pro-opiomelanocortin system in the rat. Brain Res. 420, 57-65.